Kestra Advisory Services LLC increased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) by 6.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,217 shares of the company's stock after acquiring an additional 993 shares during the quarter. Kestra Advisory Services LLC's holdings in Doximity were worth $490,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of DOCS. Vanguard Group Inc. boosted its position in Doximity by 81.2% during the first quarter. Vanguard Group Inc. now owns 7,501,908 shares of the company's stock worth $390,774,000 after acquiring an additional 3,362,575 shares during the last quarter. FMR LLC boosted its position in Doximity by 42.3% during the second quarter. FMR LLC now owns 7,737,391 shares of the company's stock worth $269,416,000 after acquiring an additional 2,298,400 shares during the last quarter. Clearbridge Investments LLC boosted its position in Doximity by 559.5% during the first quarter. Clearbridge Investments LLC now owns 2,682,876 shares of the company's stock worth $139,751,000 after acquiring an additional 2,276,056 shares during the last quarter. Baird Financial Group Inc. boosted its position in Doximity by 2,033.6% during the second quarter. Baird Financial Group Inc. now owns 1,599,204 shares of the company's stock worth $55,684,000 after acquiring an additional 1,524,251 shares during the last quarter. Finally, Invesco Ltd. boosted its position in Doximity by 141.3% during the first quarter. Invesco Ltd. now owns 2,410,842 shares of the company's stock worth $125,581,000 after acquiring an additional 1,411,849 shares during the last quarter. 52.48% of the stock is currently owned by institutional investors and hedge funds.
Get Doximity alerts:Analyst Upgrades and Downgrades
Several research firms have weighed in on DOCS. Morgan Stanley lowered shares of Doximity from an "equal weight" rating to an "underweight" rating and decreased their target price for the company from $32.00 to $29.00 in a report on Friday, January 6th. Evercore ISI boosted their target price on shares of Doximity from $28.00 to $32.00 in a report on Friday, November 11th. Piper Sandler decreased their target price on shares of Doximity from $39.00 to $35.00 in a report on Friday, November 11th. Wells Fargo & Company boosted their target price on shares of Doximity from $38.00 to $44.00 and gave the company an "overweight" rating in a report on Friday, November 11th. Finally, BTIG Research began coverage on shares of Doximity in a report on Thursday, October 13th. They issued a "neutral" rating on the stock. Two analysts have rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, Doximity presently has a consensus rating of "Hold" and an average price target of $41.40.
Doximity Stock Up 4.5 %
Shares of DOCS opened at $34.95 on Friday. Doximity, Inc. has a fifty-two week low of $22.91 and a fifty-two week high of $64.95. The firm's 50 day moving average price is $33.46 and its 200 day moving average price is $33.14. The company has a market cap of $6.73 billion, a P/E ratio of 53.77, a PEG ratio of 17.45 and a beta of 0.86.Doximity (NASDAQ:DOCS – Get Rating) last announced its earnings results on Thursday, November 10th. The company reported $0.12 earnings per share for the quarter, hitting the consensus estimate of $0.12. Doximity had a net margin of 36.70% and a return on equity of 16.41%. The firm had revenue of $102.19 million for the quarter, compared to the consensus estimate of $99.86 million. Research analysts forecast that Doximity, Inc. will post 0.52 earnings per share for the current year.
About Doximity
(Get Rating)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
- Get a free copy of the StockNews.com research report on Doximity (DOCS)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.